- Home
- LRMR vs INV Comparison
LRMR vs INV Comparison
Compare LRMR & INV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- INV
- Stock Information
- Founded
- LRMR N/A
- INV 2015
- Country
- LRMR United States
- INV United States
- Employees
- LRMR N/A
- INV N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- INV
- Sector
- LRMR Health Care
- INV
- Exchange
- LRMR Nasdaq
- INV NYSE
- Market Cap
- LRMR 183.8M
- INV 173.3M
- IPO Year
- LRMR N/A
- INV N/A
- Fundamental
- Price
- LRMR $1.91
- INV $3.17
- Analyst Decision
- LRMR Strong Buy
- INV Strong Buy
- Analyst Count
- LRMR 9
- INV 2
- Target Price
- LRMR $19.00
- INV $14.00
- AVG Volume (30 Days)
- LRMR 1.0M
- INV 73.1K
- Earning Date
- LRMR 05-08-2025
- INV 04-11-2025
- Dividend Yield
- LRMR N/A
- INV N/A
- EPS Growth
- LRMR N/A
- INV N/A
- EPS
- LRMR N/A
- INV N/A
- Revenue
- LRMR N/A
- INV $1,220,000.00
- Revenue This Year
- LRMR N/A
- INV $11.64
- Revenue Next Year
- LRMR N/A
- INV $1,305.29
- P/E Ratio
- LRMR N/A
- INV N/A
- Revenue Growth
- LRMR N/A
- INV 9.22
- 52 Week Low
- LRMR $1.61
- INV $3.04
- 52 Week High
- LRMR $11.20
- INV $18.75
- Technical
- Relative Strength Index (RSI)
- LRMR 39.39
- INV N/A
- Support Level
- LRMR $1.76
- INV N/A
- Resistance Level
- LRMR $1.91
- INV N/A
- Average True Range (ATR)
- LRMR 0.17
- INV 0.00
- MACD
- LRMR 0.03
- INV 0.00
- Stochastic Oscillator
- LRMR 46.15
- INV 0.00
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.